The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection.
about
Neuroprotection Mediated by P2Y13 Nucleotide Receptors in NeuronsNRF2-regulation in brain health and disease: implication of cerebral inflammationBiphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytesMuscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophreniaComputational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticityTranscription factors NRF2 and NF-κB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation.Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptorsTherapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.Pharmacotherapy of glaucoma.A pivotal role of GSK-3 in synaptic plasticity.Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway.The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.Walnut supplementation reverses the scopolamine-induced memory impairment by restoration of cholinergic function via mitigating oxidative stress in rats: a potential therapeutic intervention for age related neurodegenerative disorders.Protocatechualdehyde Protects Against Cerebral Ischemia-Reperfusion-Induced Oxidative Injury Via Protein Kinase Cε/Nrf2/HO-1 Pathway.Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway.Specificity of Stress-Responsive Transcription Factors Nrf2, ATF4, and AP-1.Ajoene, a stable garlic by-product, has an antioxidant effect through Nrf2-mediated glutamate-cysteine ligase induction in HepG2 cells and primary hepatocytes.The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
P2860
Q27009271-62F1AF5E-8908-4AE7-BD83-DE6669548360Q28397785-FA318014-2291-48E5-B4A0-B74796241873Q28397804-63152831-616A-4CB9-8D3E-6FF07C56D6BBQ30459624-4AFB3ECE-6071-4793-9C9A-9ADC5895F2E1Q33611723-A02D8A88-3703-483F-9D1A-908C6FD750F1Q34075866-F0DE3E4A-C023-4B96-BB2B-132399D53420Q34545452-955257EF-FA8D-472B-A4BF-163506214BD1Q34678974-2F0B9661-53B2-4E37-99FE-6E48773827DCQ35138049-1FD9D73E-CAD6-4BFB-B47B-294DFBC234E9Q35757839-90F1A43F-7FBD-4E08-88C0-17178859698DQ37883102-D6E6DC77-92A0-4099-AFD7-8CF5570610ACQ38889475-3E689A99-2338-4317-90D7-DDFFEC429E09Q42141815-D0A825F9-01FA-4106-93E2-88C768186817Q45069944-5F40C2A4-8596-44B2-A9CD-44D0880A9140Q46609197-6D60274C-4684-4547-B32B-A1D0F8FC827DQ48326514-AB10AE8E-2F2A-4EF7-B662-D0A8CF1D8375Q51712722-7D5B15A4-17DE-4FDE-86D4-CFDC83ECA399Q54428424-68F9C6C0-F719-4359-B0A5-49385DB4E4BFQ57177786-3A7D6E0F-9AA1-4BE3-8241-FE4A5AE734D9
P2860
The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The muscarinic M1 receptor act ...... smission with neuroprotection.
@en
The muscarinic M1 receptor act ...... smission with neuroprotection.
@nl
type
label
The muscarinic M1 receptor act ...... smission with neuroprotection.
@en
The muscarinic M1 receptor act ...... smission with neuroprotection.
@nl
prefLabel
The muscarinic M1 receptor act ...... smission with neuroprotection.
@en
The muscarinic M1 receptor act ...... smission with neuroprotection.
@nl
P1476
The muscarinic M1 receptor act ...... nsmission with neuroprotection
@en
P2093
Marta Salinas
Sandra Espada
P2860
P304
P356
10.1111/J.1471-4159.2009.06208.X
P407
P577
2009-06-12T00:00:00Z